Public filings / TSHA on Yahoo Finance (opens in a new tab)
TSHA: insider buying, 13F holders, analyst moves
Taysha Gene Therapies Inc - US
A summary of public filings about Taysha Gene Therapies Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
6 of our 100 managers hold TSHA
Combined reported value $461.4M; 2 sold out since Q1 2026.
Holders among our 100 managers: 4 in Q3 2023, 6 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors | $162.7M | 1.46% | Added |
| RA Capital | $160.4M | 1.39% | Unchanged |
| RTW Investments | $92.3M | 0.79% | Trimmed |
| Baker Bros. Advisors | $27.3M | 0.14% | Unchanged |
| Farallon Capital | $15.3M | 0.09% | New |
| Polen Capital | $3.3M | 0.03% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.